Invitation to a press conference on Bittium Corporation’s Half Year Financial Report January-June 2019

Press Release

Free for publication on August 1, 2019 at 10.00 am (CEST+1)

Invitation to a press conference on Bittium Corporation’s Half Year Financial Report January-June 2019

Bittium Corporation’s Half Year Financial Report January-June 2019 will be published on Thursday, August 8, 2019, at 8.00 am (CEST+1). The release will be available on company’s website www.bittium.com immediately after the publication.

Bittium will hold a webcast and telephone conference for media, analysts and institutional investors on August 8, 2019, at 9.00 am (CEST+1). The conference will be held in Finnish. Bittium will also hold a webcast and telephone conference for media, analysts and institutional investors in English on the same day at 11.00 am (CEST+1).

Link to the Finnish webcast: https://bittium.videosync.fi/2019-q2-tulokset

Link to the English webcast: https://bittium.videosync.fi/2019-q2-results

Dial-in numbers for the conference call are: FI: +358 981 710 310, SE: +46 856 642 651, UK: +44 333 300 08 04 ja US: +1 631 913 14 22

PIN code: 87033397#

A recording of the webcast and the presentation will be available after the conference on Bittium’s website at www.bittium.com/investors.

Further information:

Karoliina Fyrstén
Director, Corporate Communications and Marketing
Tel. +358 40 344 2789

Distribution:

Main media
www.bittium.com/investors

Bittium

Bittium specializes in the development of reliable, secure communications and connectivity solutions leveraging its 30 year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. Complementing its communications and connectivity solutions, Bittium offers proven information security solutions for mobile devices and portable computers. Bittium also provides healthcare technology products and services for biosignal measuring in the areas of cardiology, neurology, rehabilitation, occupational health and sports medicine. Net sales in 2018 were EUR 62.8 million and operating profit was EUR 2.8 million. Bittium is listed on Nasdaq Helsinki. www.bittium.com

Subscribe